Amsterdam-based Neurocast has developed a platform that turns routine smartphone use into a neurological data stream.

Sanofi joins a growing chorus of drugmakers boosting their U.S. operations in the face of President Trump's trade policies.

Sanofi expects to add “a significant number of high-paying jobs” in the U.S. with $20 billion investment through 2030.

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in difficulty speaking ...

Oklahoma scientists find interferon-beta may help MS patients on B cell therapy fight infections like flu and Covid-19, new ...

Despite advances in treatment, people with multiple sclerosis (MS) continue to face stark inequalities in care. It’s time to ...

New evidence added to the literature that paramagnetic rim lesions (PRLs) may be a biomarker of disability accumulation in ...

TG Therapeutics reported strong revenue growth, driven by Briumvi's success in MS treatment. Find out why I upgraded my ...

Sanofi is racing to raise the flag on meningitis ... which are to be further showcased at multiple touchpoints throughout the event. The #59 car was unveiled in Paris on April 29 in a ...

Multiple sclerosis (MS) can be unpredictable, with flares of debilitating symptoms like weakness, numbness, thought processing issues, and balance challenges. Managing your diet along with other ...

When you have chronic disease, you’re not like most people. Multiple sclerosis (MS), autoimmune forms of arthritis, and many other conditions can cause extreme fatigue. On a bad day, you may not ...

The four anti-CD20 drugs used in the U.S. to treat relapsing MS -- ocrelizumab, ofatumumab, and ublituximab (Briumvi; ...